The mechanism of the long-term blood pressure lowering effect of converting enzyme inhibition is uncertain.Nine patients (mean age 56; 5 male, 4 female; 7 white and 2 black) with previous severe essential hypertension who had been treated with captopril 25 mg t.d.5. and a diuretic for at least 6 months had their captopril stopped. The diuretic was continued throughout the study. Following the withdrawal of captopril patients were seen at 2, 12, 24, 48 and 72 hrs after the last dose of captopril until either their supine systolic blood pressure rose above 170 mmHg or their diastolic pressure above 104 mmHg at which time treatment with captopril was recommenced.At 12 hrs after withdrawal of captopril supine blood pressure had risen significantly compared to 2 hrs after the last dose (138/88?3.7/3.6-+ 157/99?5.6/3.6 mmHg (P<0.02)). This rise in blood pressure was associated with a rise in plasma angiotensin I1 from 12.1T2.0 to 19.2z3.7 pmol/L (P(0.005) and a fall in plasma renin activity from 6.722.2 to 4.2t1.3 ng/ml/hr (P <
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.